LC–MS/MS assay of ropinirole in rat biological matrices: elimination of lysoglycerophosphocholines-based matrix effect

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clinic Proceedings 81(1), 17–27 (2007).
  Google Scholar
• 2 Adler CH, Sethi KD, Hauser R et al. Ropinirole for the treatment of early Parkinson's disease. Neurology 49(2), 393–399 (1997).
  Medline CASGoogle Scholar
• 3 Brunt E, Brooks D, Korczyn A, Montastruc J-L, Stocchi F, Group S. A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-DOPA. J. Neural Transm. 109(4), 489–501 (2002).
  Medline CASGoogle Scholar
• 4 De Caro V, Giandalia G, Siragusa MG, Sutera FM, Giannola LI. New prospective in treatment of Parkinson's disease: studies on permeation of ropinirole through buccal mucosa. Int. J. Pharm. 429(1–2), 78–83 (2012).
  Medline CASGoogle Scholar
• 5 Kaye CM, Nicholls B. Clinical pharmacokinetics of ropinirole. Clin. Pharmacokinet. 39(4), 243–254 (2000).
  Medline CASGoogle Scholar
• 6 Khan S, Patil K, Bobade N, Yeole P, Gaikwad R. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J. Drug Target. 18(3), 223–234 (2010).
  Medline CASGoogle Scholar
• 7 Jay GB, Sandipkumar DP, Saisivam SS. Formulation and evaluation of fast disintegrating sublingual tablets of ropinirole hydrochloride. Int. J. Pharm. Sci. Rev. Res. 29(1), 268–275 (2014).
  Google Scholar
• 8 Azeem A, Talegaonkar S, Negi LM, Ahmad FJ, Khar RK, Iqbal Z. Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation. Int. J. Pharm. 422(1–2), 436–444 (2012).
  Medline CASGoogle Scholar
• 9 Takeda A, Tamano H, Imano S, Oku N. Increases in extracellular zinc in the amygdala in acquisition and recall of fear experience and their roles in response to fear. Neuroscience 168(3), 715–722 (2010). • Provides the formulation of artificial cerebrospinal fluid.
  Medline CASGoogle Scholar
• 10 Dhuria SV, Hanson LR, Frey WH 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 99(4), 1654–1673 (2010).
  Medline CASGoogle Scholar
• 11 Lochhead JJ, Wolak DJ, Pizzo ME, Thorne RG. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J. Cereb. Blood Flow Metab. 35(3), 371–381 (2015).
  Medline CASGoogle Scholar
• 12 Pardeshi CV, Belgamwar VS, Tekade AR, Surana SJ. Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. J. Mater. Sci. Mater. Med. 24(9), 2101–2115 (2013).
  Medline CASGoogle Scholar
• 13 Michinaga S, Hisatsune A, Isohama Y, Katsuki H. An anti-Parkinson drug ropinirole depletes orexin from rat hypothalamic slice culture. Neurosci. Res. 68(4), 315–321 (2010).
  Medline CASGoogle Scholar
• 14 Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata-Ichikawa E, Ogawa N. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 838(1–2), 51–59 (1999).
  Medline CASGoogle Scholar
• 15 Tel BC, Zeng BY, Cannizzaro C, Pearce RK, Rose S, Jenner P. Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience 115(4), 1047–1058 (2002).
  Medline CASGoogle Scholar
• 16 Oddo M, Villa F, Citerio G. Brain multimodality monitoring: an update. Curr. Opin. Crit. Care 18(2), 111–118 (2012).
  MedlineGoogle Scholar
• 17 Schaeftlein A, Minichmayr IK, Kloft C. Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data. Eur. J. Pharm. Sci. 57, 68–73 (2014). • A research article on PK study using microdialysis sampling technique.
  Medline CASGoogle Scholar
• 18 Nirogi R, Kandikere V, Bhyrapuneni G et al. Approach to reduce the non-specific binding in microdialysis. J. Neurosci. Methods 209(2), 379–387 (2012).
  Medline CASGoogle Scholar
• 19 Gottas A, Oiestad EL, Boix F et al. Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats. Br. J. Pharmacol. 170(3), 546–556 (2013).
  Medline CASGoogle Scholar
• 20 Zhang YJ, Wu L, Zhang QL, Li J, Yin FX, Yuan Y. Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling. J. Ethnopharmacol. 136(1), 129–136 (2011).
  Medline CASGoogle Scholar
• 21 Bhatt J, Jangid A, Shetty R et al. Rapid and sensitive liquid chromatography-mass spectrometry method for determination of ropinirole in human plasma. J. Pharm. Biomed. Anal. 40(5), 1202–1208 (2006).
  Medline CASGoogle Scholar
• 22 Bharathi DV, Jagadeesh B, Kumar SS et al. Highly sensitive method for the determination of ropinirole with a lower limit of quantitation of 3.45 pg/ml in human plasma by LC-ESI-MS/MS: application to a clinical pharmacokinetic study. Biomed. Chromatogr. 23(5), 557–562 (2009).
  Medline CASGoogle Scholar
• 23 Chunduri RHB, Dannana GS. Development and validation of LC–MS/MS method for simultaneous quantification of pramipexole, ropinirole and rasagiline in human plasma and its application to a pharmacokinetic study. World J. Pharm. Pharm. Sci. 4(11), 1390–1408 (2015). •• Describes an LC–MS/MS method for simultaneous quantification of pramipexole, ropinirole and rasagiline in human plasma by SPE.
  CASGoogle Scholar
• 24 Wen AD, Jia YY, Luo XX, Bi LL, Chen XY, Zhong DF. The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers. J. Pharm. Biomed. Anal. 43(2), 774–778 (2007). •• Describes an LC–MS/MS method for quantitation of ropinirole in human plasma by protein precipitation.
  Medline CASGoogle Scholar
• 25 Ismaiel OA, Zhang T, Jenkins RG, Karnes HT. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(31), 3303–3316 (2010). •• An important research article covering multiple aspects of matrix effects caused by phospholipids in MS.
  Medline CASGoogle Scholar
• 26 Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services US FDA, Rockville, MD, USA (2013). www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdf.
  Google Scholar
• 27 Guo W, Li G, Yang Y, Yang C, Si L, Huang J. LC–MS/MS analysis of pramipexole in mouse plasma and tissues: elimination of lipid matrix effects using weak cation exchange mode based solid-phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 988, 157–165 (2015).
  Medline CASGoogle Scholar
• 28 Cao P, Li G, Huang L et al. Screening of stabilizers for LC–MS/MS analysis of clevidipine and its primary metabolite in dog whole blood. Bioanalysis 7(12), 1457–1469 (2015).
  CASGoogle Scholar
• 29 Clement R, Malinovsky JM, Dollo G, Le Corre P, Chevanne F, Le Verge R. In vitro and in vivo microdialysis calibration using retrodialysis for the study of the cerebrospinal distribution of bupivacaine. J. Pharm. Biomed. Anal. 17(4–5), 665–670 (1998).
  Medline CASGoogle Scholar
• 30 Jaquins-Gerstl A, Shu Z, Zhang J, Liu Y, Weber SG, Michael AC. Effect of dexamethasone on gliosis, ischemia, and dopamine extraction during microdialysis sampling in brain tissue. Anal. Chem. 83(20), 7662–7667 (2011).
  Medline CASGoogle Scholar
• 31 Brodnik Z, Double M, Jaskiw GE. Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion. Psychopharmacology (Berl.) 227(2), 363–371 (2013). • Gives the coordinates of striatum in rat brain.
  Medline CASGoogle Scholar
• 32 Chaurasia CS, Muller M, Bashaw ED et al. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm. Res. 24(5), 1014–1025 (2007). • Describes the calibration method of microdialysis probe.
  Medline CASGoogle Scholar
• 33 Bagger M, Bechgaard E. A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug. Int. J. Pharm. 269(2), 311–322 (2004).
  Medline CASGoogle Scholar
• 34 Akdogan I, Kiroglu Y, Onur S, Karabuluti N. The volume fraction of brain ventricles to total brain volume: a computed tomography stereological study. Folia Morphol. (Warsz) 69(4), 193–200 (2010).
  Medline CASGoogle Scholar
• 35 Notkina N, Dahyot-Fizelier C, Gupta AK. In vivo microdialysis in pharmacological studies of antibacterial agents in the brain. Br. J. Anaesth. 109(2), 155–160 (2012).
  Medline CASGoogle Scholar
• 36 Menacherry S, Hubert W, Justice JB Jr. In vivo calibration of microdialysis probes for exogenous compounds. Anal. Chem. 64(6), 577–583 (1992).
  Medline CASGoogle Scholar
• 37 Manconi M, Ferri R, Zucconi M et al. Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome. Mov. Disord. 26(5), 892–895 (2011). • Provides the protein binding rate of ropinirole in human plasma.
  MedlineGoogle Scholar